Literature DB >> 10819848

Effects of leuprolide acetate on low-grade endometrial stromal sarcoma.

A F Mesia1, R I Demopoulos.   

Abstract

We describe a low-grade endometrial stromal sarcoma coexistent with leiomyoma and adenomyosis treated with leuprolide acetate. We describe its histologic characteristics and clinical significance.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10819848     DOI： 10.1067/mob.2000.103939

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


  9 in total

1.  Long-term medroxyprogesterone acetate therapy for low-grade endometrial stromal sarcoma.

Authors:  Mika Mizuno; Yasushi Yatabe; Akihiro Nawa; Toru Nakanishi
Journal:  Int J Clin Oncol       Date:  2011-08-10       Impact factor: 3.402

2.  Expression of androgen receptors in benign and malignant endometrial stromal neoplasms.

Authors:  Farid Moinfar; Peter Regitnig; Ali Dastranj Tabrizi; Helmut Denk; Fattaneh A Tavassoli
Journal:  Virchows Arch       Date:  2004-03-06       Impact factor: 4.064

3.  Investigation of hormone receptor expression and its prognostic value in endometrial stromal sarcoma.

Authors:  Jeong-Yeol Park; Min-Hyun Baek; Yangsoon Park; Young-Tak Kim; Joo-Hyun Nam
Journal:  Virchows Arch       Date:  2018-06-04       Impact factor: 4.064

4.  Low grade endometrial stromal sarcoma of uterine corpus, a clinico-pathological and survey study in 14 cases.

Authors:  Tahereh Ashraf-Ganjoei; Nadereh Behtash; Mamak Shariat; Asamosadat Mosavi
Journal:  World J Surg Oncol       Date:  2006-08-09       Impact factor: 2.754

5.  Long-term survival of patients with recurrent endometrial stromal sarcoma: a multicenter, observational study.

Authors:  Hiroyuki Yamazaki; Yukiharu Todo; Kenrokuro Mitsube; Hitoshi Hareyama; Chisa Shimada; Hidenori Kato; Katsushige Yamashiro
Journal:  J Gynecol Oncol       Date:  2015-04-16       Impact factor: 4.401

6.  Long-term survival in low-grade endometrial stromal sarcoma with childbirth and multidisciplinary treatment: a case report.

Authors:  Osamu Maeda; Suzuko Moritani; Shu Ichihara; Takami Inoue; Yutaka Ishihara; Shinichi Yamamoto; Makoto Ito; Yoko Matsumura; Kumiko Sugiyama; Maiko Horio; Ikuyo Kondo
Journal:  J Med Case Rep       Date:  2015-10-20

Review 7.  Hormonal therapy in uterine sarcomas.

Authors:  Yuqin Zang; Mengting Dong; Kai Zhang; Chao Gao; Fei Guo; Yingmei Wang; Fengxia Xue
Journal:  Cancer Med       Date:  2019-03-21       Impact factor: 4.452

Review 8.  New Insights into Hormonal Therapies in Uterine Sarcomas.

Authors:  Elena Maccaroni; Valentina Lunerti; Veronica Agostinelli; Riccardo Giampieri; Laura Zepponi; Alessandra Pagliacci; Rossana Berardi
Journal:  Cancers (Basel)       Date:  2022-02-12       Impact factor: 6.639

Review 9.  Treatment of early uterine sarcomas: disentangling adjuvant modalities.

Authors:  Flora Zagouri; Athanasios-Meletios Dimopoulos; Stelios Fotiou; Vassilios Kouloulias; Christos A Papadimitriou
Journal:  World J Surg Oncol       Date:  2009-04-08       Impact factor: 2.754
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.